Experimental ocular tuberculosis in guinea pigs

Archives of Ophthalmology

Volumn 127, Issue 9, 2009, Pages 1162-1166

  Rao, Narsing A ^a   Albini, Thomas A ^b   Kumaradas, Mirnalini ^a   Pinn, Michael L ^c   Fraig, Mostafa M ^c   Karakousis, Petros C ^c,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ACID FAST BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULOMATOUS INFLAMMATION; GUINEA PIG; HISTOLOGY; LUNG TUBERCULOSIS; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OCULAR TUBERCULOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UVEA;

AEROSOLS; ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; GUINEA PIGS; ISONIAZID; LUNG; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PYRAZINAMIDE; RIFAMPIN; SPLEEN; TUBERCULOSIS, OCULAR; TUBERCULOSIS, PULMONARY;

EID: 70349255601     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.220     Document Type: Article

References (24)

1. World Health Organization tuberculosis fact sheet. http://www.who.int/ mediacentre /factsheets/fs104/en/. Accessed June 12, 2009.
2. Kaufmann SH, McMichael AJ. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med. 2005;11(4)(suppl):S33-S44.
3. Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis [published online December 19, 2003]. Clin Infect Dis. 2004;38 (2):199-205.
4. Karakousis PC, Chaisson RE. Mycobacterial infections and HIV infection. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, eds. Fishman's Pulmonary Diseases and Disorders. 4th ed. New York, NY: McGraw Hill; 2008: 2487-2497.
5. Gupta V, Gupta A, Rao NA. Intraocular tuberculosis: an update. Surv Ophthalmol. 2007;52(6):561-587.
6. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103(2):131-136.
7. Varma D, Anand S, Reddy AR, et al. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye. 2006;20(9):1068-1073.
8. Gupta V, Gupta A, Arora S, Bambery P, Dogra MR, Agarwal A. Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology. 2003;110(9):1744-1749. (Pubitemid 37025433)
9. Babu RB, Sudharshan S, Kumarasamy N, Therese L, Biswas J. Ocular tuberculosis in acquired immunodeficiency syndrome. Am J Ophthalmol. 2006;142 (3):413-418. (Pubitemid 44767527)
10. Ortega Larrocea G, Bobadilla del Valle M, Ponce de León A, Sifuentes Osornio J. Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. Arch Med Res. 2003; 34(2):116-119. (Pubitemid 36434067)
11. Flynn JL, Chan J. Animal models of tuberculosis. In: Rom WN, Garay SM, eds. Tuberculosis. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004: 237-250.
12. Finnoff WC. The relation of tuberculosis to chronic uveitis. Am J Ophthalmol. 1931;14(12):1208-1227.
13. Woods AC. Experimental studies on the pathogenesis and treatment of ocular tuberculosis. Br J Ophthalmol. 1949;33(4):197-228.
14. Woods AC, Wood R, Senterfit LB. Studies in experimental ocular tuberculosis, XVIII: the effect of cortisone combined with specific antibacterial therapy on experimental ocular tuberculosis in the immune-allergic rabbit. AMA Arch Opthalmol. 1958;59(4):559-578.
15. Lepri G, Capalbi S. Influence of terramycin on the course of experimental ocular tuberculosis: comparative activity of terramycin, streptomycin, and both antibiotics combined. Br J Ophthalmol. 1952;36(2):75-80.
16. Capuano SV III, Croix DA, Pawar S, et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun. 2003;71(10): 5831-5844. (Pubitemid 37205637)
17. Woods AC, Burky EL, Friedenwald JS. Experimental studies of ocular tuberculosis. Arch Ophthalmol. 1938;19(2):245-250.
18. Walsh GP, Tan EV, Dela Cruz EC, et al. The Philippine cynomolgus monkey (Mucaca fascicularis) provides a new non-human primate model of tuberculosis that resembles human disease. Nat Med. 1996;2(4):430-436.
19. Klinkenberg LG, Sutherland LA, Bishai WR, Karakousis PC. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J Infect Dis. 2008;198(2):275-283.
20. Karakousis PC, Parry Z, Klinkenberg LG, Pinn ML, Nuermberger E, Grosset J. A guinea pig model of TB chemotherapy. Paper presented at: US Japan Cooperative Medical Sciences Program 43rd Tuberculosis and Leprosy Research Conference; July 10, 2008; Baltimore, MD.
21. Sheu SJ, Shyu JS, Chen LM, Chen YY, Chirn SC, Wang JS. Ocular manifestations of tuberculosis. Ophthalmology. 2001;108(9):1580-1585.
22. Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109(5):851-857. (Pubitemid 34465215)
23. Donahue HC. Ophthalmic experience in a tuberculosis sanitorium.AmJ Ophthalmol. 1967;64(4):742-748.
24. Rao NA, Saraswathy S, Smith RE. Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium. Arch Ophthalmol. 2006; 124(12):1777-1779. (Pubitemid 44913204)